Sports nutrition

NYAG affair will have implications for probiotics suppliers, exec says

Probiota Americas

NYAG affair will have implications for probiotics suppliers, exec says

By Hank Schultz

According to one prominent executive, for the probiotics industry, the fallout from the NYAG affair should be fairly straightforward:  Make sure you know how to do what you’re supposed to do in the first place. Identify and count, it’s as simple as that.

ChromaDex extends earnings streak, cuts losses in half

ChromaDex extends earnings streak, cuts losses in half

By Hank Schultz

ChromaDex Corp. notched its fourth consecutive quarter of record earnings with its Q1 2015 earnings report which it made public this week. The company reported net sales of $5.3 million, an increase of 71% year-over-year. The company also halved its net...

Special Edition: Supply in the time of Schneiderman

Special Edition: Supply in the time of Schneiderman

By Hank Schultz

The supply end of the dietary supplement sector has come under extraordinary pressures of late. While the NYAG affair has called the integrity of the supply chain into question, demand continues to increase for certain ingredients such as Ayurvedic herbs...

Sabinsa expands Ayurvedic herb cultivation as demand grows

Sabinsa expands Ayurvedic herb cultivation as demand grows

By Stephen Daniells

Botanical supplier Sabinsa is expanding its existing cultivation program for Indian herbs to ensure sustainable supply of ingredients such as turmeric, gac, and black ginger, in order to match demand in the global US$1.6 billion market.

Hi-Tech Pharmaceuticals suing Harvard researchers for $200 million

Hi-Tech Pharmaceuticals suing Harvard researchers for $200 million

By Stephen DANIELLS

BMPEA proponent Hi-Tech Pharmaceuticals, Inc, has filed a suit against four researchers, including Dr Pieter Cohen, alleging a recent study published in Drug Testing and Analysis is defamatory. Hi-Tech is seeking $50 million in compensatory damages and...

Durbin, Blumenthal urge FDA to take action against BMPEA

Durbin, Blumenthal urge FDA to take action against BMPEA

By Hank Schultz

US Senators Dick Durbin and Richard Blumenthal sent a letter yesterday to the Food and Drug Administration asking the agency to take action against products containing the synthetic stimulant ingredient known as BMPEA, products which the pair called both “mislabeled...

$5.9 bn US sports nutrition market unlocking mass appeal: Euromonitor

$5.9 bn US sports nutrition market unlocking mass appeal: Euromonitor

By Maggie Hennessy

Buoyed by the continued rise of protein as a super-nutrient and a growing urgency around better fitness to stave off lifestyle diseases, sports nutrition is attracting a wider audience of consumers, according to “Trends and Developments in Sports Nutrition”...

Follow us

Product Innovations